Improvement of severe alopecia areata after 9‐month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis
The Journal of Dermatology · 2023
DOI: 10.1111/1346-8138.16893 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Hideaki Uchida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Alopecia Areata, Dermatitis, Atopic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
ORCID-Profile: Masahiro Kamata, Yayoi Tada
Zitieren
APA
Uchida, H., Kamata, M., Watanabe, A., Ito, M., Fukaya, S., Hayashi, K., Fukuyasu, A., Tanaka, T., Ishikawa, T., & Tada, Y. (2023). Improvement of severe alopecia areata after 9‐month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16893
Vancouver
Uchida H, Kamata M, Watanabe A, Ito M, Fukaya S, Hayashi K, et al. Improvement of severe alopecia areata after 9‐month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16893
BibTeX
@article{Uchida2023,
author = {Uchida, Hideaki and Kamata, Masahiro and Watanabe, Ayu and Ito, Makoto and Fukaya, Saki and Hayashi, Kotaro and Fukuyasu, Atsuko and Tanaka, Takamitsu and Ishikawa, Takeko and Tada, Yayoi},
title = {Improvement of severe alopecia areata after 9‐month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis},
journal = {The Journal of Dermatology},
year = {2023},
doi = {10.1111/1346-8138.16893}
}
EUVIMED